siRNA/Inclisiran and the CV continuum - are we reinventing LDL-C management?

30 August 2025 (12:53 - 13:03)

Organised by:

About the speaker

Doctor Pam Taub

University of California San Diego, La Jolla (United States of America)

7 More presentations in this session

Presentation thumbnail

Welcome and introduction

Doctor A. Lopez Suarez (Sevilla, Spain, ES)

Presentation thumbnail

The guideline gap - are we hitting the mark in post-ACS lipid management?

Professor I. Eitel (Luebeck, DE)

Presentation thumbnail

Turning evidence into excellence - practical strategies for achieving Lipid-lowering therapy success post acute coronary syndrome

Doctor A. Lopez Suarez (Sevilla, Spain, ES)

Presentation thumbnail

Real-world evidence or real-world reality - Is Real world evidence a mirror or magnifier of RCTs?

Professor P. Perrone-Filardi (Naples, IT)

Presentation thumbnail

Early goal attainment or long-term retention - what drives better patient outcomes?

Professor P. Perrone-Filardi (Naples, IT) Doctor P. Taub (La Jolla, US)

Access the full session

Session thumbnail

Early escalation for intense lipid-lowering - the ultimate game-changer for atherosclerotic cardiovascular disease (ASCVD)?

The Event

Event poster

ESC Congress 2025

30 August 2025 12:53 CET

You may be interested in

Congress Session

Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?

27 August 2023

Congress Session

Improving pharmacotherapy in primary prevention

30 August 2025

Congress Presentation

Real-world and implementation science: insights about siRNA

1 September 2024

Congress Presentation

How do we achieve lower for longer LDL-C levels in patients who can't wait?

28 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources